Caffeine, creatine, GRIN2A and Parkinson’s disease progression

Caffeine is neuroprotective in animal models of PD and caffeine intake is inversely associated with the risk of Parkinson’s disease (PD). This association may be influenced by the genotype of GRIN2A, which encodes an NMDA-glutamate-receptor subunit. In two placebo-controlled studies, we detected no...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurol Sci
Autori principali: Simon, David K., Wu, Cai, Tilley, Barbara C., Lohmann, Katja, Klein, Christine, Payami, Haydeh, Wills, Anne-Marie, Aminoff, Michael J., Bainbridge, Jacquelyn, Dewey, Richard, Hauser, Robert A., Schaake, Susen, Schneider, Jay S., Sharma, Saloni, Singer, Carlos, Tanner, Caroline M., Truong, Daniel, Wei, Peng, Wong, Pei Shieen, Yang, Tianzhong
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386398/
https://ncbi.nlm.nih.gov/pubmed/28320167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2017.02.032
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi